Plunkett Research Online: Alimera Sciences Inc

ALIMERA SCIENCES INC (ALIM:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Alimera Sciences, Inc. is a biopharmaceutical company researching, developing and commercializing prescription ophthalmic pharmaceuticals, with a primary focus on diseases affecting the retina. Iluvien, the firm’s most advanced product candidate, is targeted for the treatment of diabetic macular ed.....



Alimera Sciences Inc
Ticker: ALIM
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 678 990-5740
Fax:
Address: 6120 Windward Parkway
Suite 290
Alpharetta, GA 30005 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals Research & Development
Retinal Disease Medication
ContactsDescription
C. MyersCEO/Director/Founder
Richard EiswirthCFO/Chief Accounting Officer/President
See More
Alimera Sciences, Inc. is a biopharmaceutical company researching, developing and commercializing prescription ophthalmic pharmaceuticals, with a primary focus on diseases affecting the retina. Iluvien, the firm’s most advanced product candidate, is targeted for the treatment of diabetic macular ed.....See More See More

Auditor: Grant Thornton LLP
Legal Advisor: Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Iluvien
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: